Grant: Planning Grants - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
University of Calgary
$15,000.00
Developing Cardiovascular Quality Indicators for Rheumatoid Arthritis
EF 2012-13
Résumé
Rheumatoid arthritis affects 1 in 100 people causing joint destruction and disability if untreated. The inflammation from the arthritis also has another important consequence: an increased risk of premature heart attacks and strokes. This risk is 50% higher than in the general population and is a major cause of premature death in patients with RA. Current RA treatment guidelines emphasize early diagnosis and aggressive management of the symptoms from the joints, but do not address who should be screened for heart disease or how. Our goal is to bring together medical experts in heart disease and RA as well as RA patients to develop a set of measures by which we can determine the quality of healthcare being provided to manage heart disease risk in RA. This allows us to also identify where the care being provided needs to be improved. This will be done using state of the art consensus methodology online. This work will also be applicable to other chronic inflammatory conditions associated with increased heart disease risk.
Programme
Planning Grants - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
284096
Name
Barber Claire E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Planning Grants
Projecttitle
Developing Cardiovascular Quality Indicators for Rheumatoid Arthritis
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Calgary
Cihramount2
$15,000
Cihrequipment2
$0
Programname2
Planning Grants - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Keyworddelim
Cardiovascular Disease; Quality Indicators; Rheumatoid Arthritis
Abstract
Rheumatoid arthritis affects 1 in 100 people causing joint destruction and disability if untreated. The inflammation from the arthritis also has another important consequence: an increased risk of premature heart attacks and strokes. This risk is 50% higher than in the general population and is a major cause of premature death in patients with RA. Current RA treatment guidelines emphasize early diagnosis and aggressive management of the symptoms from the joints, but do not address who should be screened for heart disease or how. Our goal is to bring together medical experts in heart disease and RA as well as RA patients to develop a set of measures by which we can determine the quality of healthcare being provided to manage heart disease risk in RA. This allows us to also identify where the care being provided needs to be improved. This will be done using state of the art consensus methodology online. This work will also be applicable to other chronic inflammatory conditions associated with increased heart disease risk.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Barber, Claire E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $15,000~ $0~